Literature DB >> 30878628

Challenges and safety of beta-lactam desensitization during extracorporeal membrane oxygenation.

Dinah Foer1, Kathleen Marquis2, Natasha Romero3, Mariana C Castells2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 30878628      PMCID： PMC6555662          DOI： 10.1016/j.anai.2019.03.005

Source DB:  PubMed          Journal:  Ann Allergy Asthma Immunol        ISSN： 1081-1206            Impact factor:   6.347


× No keyword cloud information.
  9 in total

Review 1.  Optimising drug dosing in patients receiving extracorporeal membrane oxygenation.

Authors:  Vesa Cheng; Mohd-Hafiz Abdul-Aziz; Jason A Roberts; Kiran Shekar
Journal:  J Thorac Dis       Date:  2018-03       Impact factor: 2.895

Review 2.  Rapid desensitization for hypersensitivity reactions to medications.

Authors:  Mariana Castells
Journal:  Immunol Allergy Clin North Am       Date:  2009-08       Impact factor: 3.479

Review 3.  The 3 Cs of Antibiotic Allergy-Classification, Cross-Reactivity, and Collaboration.

Authors:  Jason A Trubiano; Cosby A Stone; M Lindsay Grayson; Karen Urbancic; Monica A Slavin; Karin A Thursky; Elizabeth J Phillips
Journal:  J Allergy Clin Immunol Pract       Date:  2017-08-23

4.  Beta-lactam allergy in adults with cystic fibrosis.

Authors:  Judith A Burrows; Lisa M Nissen; Carl M J Kirkpatrick; Scott C Bell
Journal:  J Cyst Fibros       Date:  2006-12-19       Impact factor: 5.482

Review 5.  Evaluation of Altered Drug Pharmacokinetics in Critically Ill Adults Receiving Extracorporeal Membrane Oxygenation.

Authors:  Michael A Ha; Adam C Sieg
Journal:  Pharmacotherapy       Date:  2017-02-03       Impact factor: 4.705

6.  Survival of patients with cystic fibrosis on ECMO: analysis of the Extracorporeal Life Support Organization Registry.

Authors:  Don Hayes; Benjamin T Kopp; Thomas J Preston; Stephen Kirkby; Joseph D Tobias; Thomas J Papadimos; Bryan A Whitson
Journal:  Int J Clin Exp Med       Date:  2014-05-15

Review 7.  Clinical pharmacokinetics of antimicrobial drugs in cystic fibrosis.

Authors:  D J Touw
Journal:  Pharm World Sci       Date:  1998-08

8.  A safe protocol for rapid desensitization in patients with cystic fibrosis and antibiotic hypersensitivity.

Authors:  Henry J Legere; Ross I Palis; Tito Rodriguez Bouza; Ahmet Z Uluer; Mariana C Castells
Journal:  J Cyst Fibros       Date:  2009-09-08       Impact factor: 5.482

Review 9.  Cross-reactivity in β-Lactam Allergy.

Authors:  Robert J Zagursky; Michael E Pichichero
Journal:  J Allergy Clin Immunol Pract       Date:  2017-10-07
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.